Breaking News

iotaSciences to Launch Next-Gen Single-Cell Cloning Platform

The Cloning Platform XT is based on the existing Single-Cell Cloning Platform and iotaSciences’ proprietary fluid-shaping technology.

Author Image

By: Charlie Sternberg

Associate Editor

iotaSciences, a provider of single-cell biology handling solutions, will unveil its next-generation Single-Cell Cloning Platform XT at the Cell 2024 conference in London.   The new platform, an upgrade to its predecessor, leverages iotaSciences’ proprietary fluid-shaping technology to automate single-cell isolation, culture, and transfer. This enhanced automation increases throughput and speed while maintaining high-quality results.   A key feature of the platform is the integration of SCAI ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters